During the financial year 2023/24, the busiest hospital provider in England was the ************************************************ with over *** thousand admissions. This trust encompasses four hospitals in the Birmingham area, one of the largest urban areas in England. The second-busiest trust this year was the ******************************************, with approximately *** thousand admissions. Accident and emergency admissionsFrom April to June 2023, there were around *** million accident and emergency (A&E) attendees (including at A&E departments not in hospitals) in England. After the drop in A&E attendances during the COVID-pandemic, numbers have risen again to previous levels, with a trend towards an increasing number of individuals seeking emergency care. Over ***** percent of A&E attendees in England in 2022/23 were first diagnosed with a sprained ankle, knee, wrist, or foot, and over **** percent were diagnosed with a respiratory infection. Furthermore, *** percent were found to have ‘no abnormality detected’ which could be detrimental to a service that is already stretched. Waiting too longOver the last few years in the A&E department, the NHS has been falling behind the target that ** percent of patients should be seen within **** hours of arrival. The last time this target was reached was back in July 2015. Not just the A&E department, but other services also require lengthy waits. It is no wonder that the ******** of respondents surveyed were fairly or very dissatisfied with the length of wait for many aspects of NHS care. Moreover, in general, levels of satisfaction with the way NHS runs is at an all-time low.

In 2022, there were an estimated 2,001 hospitals in the United Kingdom. The number of hospitals in the UK had been declining prior to 2015, standing at 1,568 in 2014, before slightly rising again in the subsequent years.

Healthcare indicators

Expenditure on health in the UK amounted to 11.3 percent of the GDP in 2022. This proportion has been increasing since 2000, with 2020 and 201 being outliers. The pressure on general practices has been increasing in the UK in the last ten years. In 2016, there were 7.8 thousand patients to each GP practice on average in the NHS England. By 2023 it came to ten thousand patients to a practice.

Opinion of healthcare in the country

The quality of British healthcare is still generally regarded as good by the majority. In a survey of nine European countries, 58 percent of British respondents rated the quality of their accessible healthcare as good, while only 14 percent regarded it as poor. This was the fifth place among countries surveyed, down from its top spot in 2018, when 73 percent of the public gave good rating. Similarly, 58 percent of Brits surveyed trusted the treatment offered, compared to only 18 percent who did not.

The size of the UK Hospital Supplies Industry market was valued at USD 29.5 Billion in 2023 and is projected to reach USD 34.7 Billion by 2032, with an expected CAGR of 5.60% during the forecast period. The hospital supplies industry in the United Kingdom is a vital component of the country's healthcare system, characterized by a comprehensive range of medical supplies and equipment essential for patient care. The UK has a well-established healthcare infrastructure, primarily through the National Health Service (NHS), which provides services to a significant portion of the population. The hospital supplies market encompasses various products, including surgical instruments, medical consumables, durable medical equipment, and infection control supplies. The UK has a comprehensive healthcare system supported by the NHS, which plays a significant role in providing medical services and supplies. This extensive infrastructure creates a consistent demand for hospital supplies to support patient care and operations. Recent developments include: In April 2022, the United Kingdom donated to Ukraine 5.29 million items of medical supplies to help the country cope with the medical emergency, which includes lifesaving medicines, wound packs, and intensive care equipment., In July 2020, BD (Becton, Dickinson, and Company) announced the receipt of a large pandemic order from the United Kingdom (U.K.) government for 65 million needles and syringes to be d.elivered by mid-September 2020 to support the U.K. vaccination effort for COVID-19.. Key drivers for this market are: The aging population in the UK is leading to a higher prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and other age-related conditions. This demographic shift drives demand for hospital supplies and medical services. . Potential restraints include: The UK healthcare system operates under a budget-constrained model, which can pressure hospitals to control costs. This may limit their ability to invest in advanced hospital supplies and technologies. . Notable trends are: There is a growing trend toward the use of disposable medical supplies in hospitals due to concerns about infection control and convenience. The demand for single-use products is expected to rise, particularly in surgical and emergency care settings. .

Snapshot img

Hospital Beds Market Size 2025-2029

The hospital beds market size is forecast to increase by USD 2.69 billion, at a CAGR of 9.9% between 2024 and 2029.

The market is experiencing significant growth due to the rising number of medical emergencies and the increase in infectious diseases. The global health crisis has highlighted the importance of having an adequate supply of hospital beds to manage the influx of patients. However, the high cost of automated hospital beds poses a challenge for healthcare providers, as they seek to balance the need for advanced technology with budget constraints. Moreover, the growing prevalence of chronic diseases, such as diabetes and cardiovascular diseases, necessitates long-term hospitalization, further increasing the demand for hospital beds. Additionally, the aging population and their subsequent healthcare needs are also contributing to market growth.
To capitalize on these opportunities, companies can focus on developing cost-effective solutions that offer advanced features, ensuring they cater to the evolving needs of healthcare providers while remaining competitive in the market. Navigating the challenges of cost and affordability will be crucial for market success, as providers seek to optimize their budgets while maintaining the highest level of patient care.

What will be the Size of the Hospital Beds Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The hospital bed market continues to evolve, with dynamic shifts in market trends and applications across various healthcare sectors. Hospital bed frames, a fundamental component of patient care, undergo constant innovation to enhance ergonomics and support systems. Mattresses with advanced pressure distribution technology cater to the unique needs of bariatric patients, while ICU beds integrate intravenous pole systems and height adjustment mechanisms for intensive care. Bedside safety features, such as fall prevention systems and bedside rails, are increasingly integrated into hospital bed designs. Bedside monitors, lighting, and call systems further enhance patient safety and comfort. Hospital bed sustainability is a growing concern, with a focus on recycling and disposal methods, as well as the use of eco-friendly materials in bed covers and linens.

Anti-embolism stockings and durability are essential considerations in hospital bed design, ensuring patient safety and longevity. Hospital bed certification standards continue to evolve, driving innovation in bedside safety and maintenance. The market for hospital bed accessories, such as overbed tables and height adjustment mechanisms, is expanding to cater to diverse patient needs. Ergonomics and aesthetics are increasingly important in hospital bed design, with a focus on patient comfort and satisfaction. The integration of electric actuators and sterilization systems further enhances the functionality and efficiency of hospital beds. The ongoing development of pressure relief systems and anti-decubitus mattresses underscores the continuous pursuit of innovation in this dynamic market.

How is this Hospital Beds Industry segmented?

The hospital beds industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Product

  Manual beds
  Semi-automated beds
  Automated beds


Application

  Intensive care
  Acute care
  Home care


End-user

  Hospitals
  Home healthcare
  Elderly care facilities
  Ambulatory surgical centers


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    UK


  APAC

    China
    India
    Japan
    South Korea


  South America

    Brazil


  Rest of World (ROW)

.

By Product Insights

The manual beds segment is estimated to witness significant growth during the forecast period.

The market encompasses a range of products designed for healthcare settings, including manual and electric beds, bariatric beds, ICU beds, and recovery room beds. These beds prioritize ergonomics, offering mattress support systems, adjustable frames, and pressure distribution systems to ensure patient comfort and support. Hospital bed sustainability is a growing concern, leading to the development of eco-friendly materials and recycling programs for bed components. Bedside tables, rails, and lighting provide added functionality, while certifications ensure safety and compliance. Hospital bed linens and covers, along with anti-embolism stockings, contribute to patient care and hygiene. Fall prevention systems and repair services ensure patient safety and bed longevity.

Operating room tables and electric actuators facilitate

This is a publication on Accident and Emergency (A&E) activity in English NHS hospitals and English NHS-commissioned activity in the independent sector. This annual publication covers the financial year ending March 2022. It contains final data and replaces the provisional data that are published each month. This is a joint publication between NHS Digital and NHS England. This collaboration enables data to be brought together from different sources enabling inclusion of a wider set of breakdowns and measures and a more complete picture to be presented. The data sources for this publication are the Emergency Care Data Set (ECDS) for2020-21 and 2021-22, HES A&E for activity prior to 2020-21 and the A&E Attendances and Emergency Admissions Monthly Situation Reports (MSitAE). This is the second year this report has been produced using ECDS in its submitted format, replacing the use of Hospital Episode Statistics (HES). Further information is available in the Data Quality Statement. The ECDS data set contains several new and additional reporting fields not previously available in HES A&E enabling new insights to be identified from data. Reported information based on these new splits and metrics presented within the report are presented as Experimental Statistics and should be used with caution. Experimental statistics are new official statistics undergoing evaluation. They are published in order to involve users and stakeholders in their development and as a means to build in quality at an early stage. More information about experimental statistics can be found on the UK Statistics Authority website. This publication releases some high level analyses of both ECDS/HES and MSitAE data relating to A&E attendances in NHS hospitals, minor injury units and walk-in centres. It includes analysis by patient demographics, time spent in A&E, distributions by time of arrival and day of week, arriving by ambulance, performance times, waits for admission and re-attendances to A&E within 7 days. The following additional analyses are also included in this report: • Comparison of 4 hour and 12 hour waits between the four home nations, England, Scotland, Northern Ireland and Wales • A&E attendances by Index of Multiple Deprivation (IMD) • A&E attendances by ethnicity • Weekly variation in attendance activity during the pandemic, by department type

In 2023, 64 percent of services received at NHS acute hospitals were considered good, whereas 25 percent required improvement. This statistic displays the overall rating of NHS acute hospitals core services in England as of August 2023.

This report shows monthly numbers of NHS Hospital and Community Health Services (HCHS) staff working in NHS Trusts and other core organisations in England (excluding primary care staff). Data are available as headcount and full-time equivalents and for all months from 30 September 2009 onwards. These data are a summary of the validated data extracted from the NHS HR and Payroll system. Additional statistics on staff in NHS Trusts and other core organisations and information for NHS Support Organisations and Central Bodies are published each: September (showing June statistics) December/January (showing September statistics) March (showing December statistics) June (showing March statistics) Quarterly NHS Staff Earnings, monthly NHS Staff Sickness Absence reports, and data relating to the General Practice workforce and the Independent Healthcare Provider workforce are also available via the Related Links below. We welcome feedback on the methodology and tables within this publication. Please email us with your comments and suggestions, clearly stating Monthly HCHS Workforce as the subject heading, via enquiries@nhsdigital.nhs.uk or 0300 303 5678.

In 2021, there were roughly 1.66 million individuals employed in hospitals in the UK, the largest number in Europe. Germany, France, and Turkey also had hospital employee numbers reaching over one million. This statistic displays the number of individuals employed in hospitals in Europe in 2021.

This horizontal bar chart displays hospital beds (per 1,000 people) by currency using the aggregation average, weighted by population in the United Kingdom. The data is filtered where the date is 2021. The data is about countries per year.

The UK hospital supplies market, a significant segment of the broader European healthcare landscape, is experiencing robust growth driven by several key factors. An aging population, increasing prevalence of chronic diseases, and advancements in medical technology are fueling demand for a wider range of sophisticated hospital supplies. Government initiatives promoting improved healthcare infrastructure and patient care further contribute to market expansion. The market is segmented by product type, with patient examination devices, operating room equipment, and disposable supplies representing significant portions of the overall revenue. Technological innovations, such as minimally invasive surgical tools and advanced diagnostic equipment, are reshaping the market, leading to increased efficiency and improved patient outcomes. However, budgetary constraints within the National Health Service (NHS) and stringent regulatory requirements represent potential challenges to sustained, rapid growth. Competitive pressures from both domestic and international suppliers also influence market dynamics, encouraging innovation and price optimization. Despite these challenges, the market is projected to maintain a healthy growth trajectory. The focus on preventative healthcare and the increasing adoption of telehealth solutions are expected to drive demand for certain product categories, particularly remote monitoring devices and telehealth-compatible equipment. Furthermore, the UK's commitment to improving its healthcare system, along with investments in research and development, should support a positive outlook for the hospital supplies market in the coming years. Companies operating in this market are likely to focus on strategic partnerships, mergers, and acquisitions to expand their product portfolios and market reach, capitalizing on opportunities presented by the evolving healthcare landscape in the UK. Given the 5.60% CAGR observed globally, a conservative estimate for the UK market would likely fall within the range of 4-6%, reflecting the complexities of the NHS and the regional economic factors. Recent developments include: In April 2022, the United Kingdom donated to Ukraine 5.29 million items of medical supplies to help the country cope with the medical emergency, which includes lifesaving medicines, wound packs, and intensive care equipment., In July 2020, BD (Becton, Dickinson, and Company) announced the receipt of a large pandemic order from the United Kingdom (U.K.) government for 65 million needles and syringes to be d.elivered by mid-September 2020 to support the U.K. vaccination effort for COVID-19.. Key drivers for this market are: Increasing Incidences of Communal Diseases, Growing Public Awareness about Hospital Acquired Infections. Potential restraints include: Increasing Incidences of Communal Diseases, Growing Public Awareness about Hospital Acquired Infections. Notable trends are: Disposable Hospital Supplies Holds the Major Share in the Market Studied.

Improving outcomes for people with multiple long term conditions is a priority as set out in the NHS long term plan. ADMISSION is a Research Collaborative funded by UK Research and Innovation and the National Institute for Health Research and Care Research that brings together scientists, clinicians and patients from five UK universities and hospitals (Newcastle University and Newcastle Hospitals NHS Foundation Trust, University of Birmingham (PIONEER – the Health Data Research UK Acute Care Hub),  Manchester Metropolitan University, University of Dundeeand University College London) to transform understanding of multiple long-term conditions in hospital patients.

As part of this, PIONEER has curated a highly granular dataset of 119,815 unique hospitalised patients focusing on the impact of multiple long term conditions. The data includes admission details, demography, initial presentation, presenting symptoms, diagnoses, treatments, therapy, medications, imaging, wards, investigations, procedures, operations and outcomes. The current dataset includes admissions from 01-01-2000 to 07-02-2024 but can be expanded to assess other timelines of interest.

Geography: The West Midlands (WM) has a population of 6 million & includes a diverse ethnic & socio-economic mix. UHB is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, 2750 beds & > 120 ITU bed capacity. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health”.

Data set availability: Data access is available via the PIONEER Hub for projects which will benefit the public or patients. This can be by developing a new understanding of disease, by providing insights into how to improve care, or by developing new models, tools, treatments, or care processes. Data access can be provided to NHS, academic, commercial, policy and third sector organisations. Applications from SMEs are welcome. There is a single data access process, with public oversight provided by our public review committee, the Data Trust Committee. Contact pioneer@uhb.nhs.uk or visit www.pioneerdatahub.co.uk for more details.

Available supplementary data: Matched controls; ambulance and community data. Unstructured data (images). We can provide the dataset in OMOP and other common data models and can build synthetic data to meet bespoke requirements.

Available supplementary support: Analytics, model build, validation & refinement; A.I. support. Data partner support for ETL (extract, transform & load) processes. Bespoke and “off the shelf” Trusted Research Environment (TRE) build and run. Consultancy with clinical, patient & end-user and purchaser access/ support. Support for regulatory requirements. Cohort discovery. Data-driven trials and “fast screen” services to assess population size.

Crude rate of cost of admissions for alcohol-related conditions (Broad definition) per head of population.

Rationale Alcohol misuse across the UK is a significant public health problem with major health, social, and economic consequences. This indicator aims to highlight the impact of alcohol-related conditions on inpatient hospital services in England. High costs of alcohol-related admissions are indicative of poor population health and high alcohol consumption. This indicator highlights the resource implications of alcohol-related conditions and supports the arguments for local health promotion initiatives. Publication of this indicator will allow national and local cost estimates to be updated and consistently monitored going forward. This measure accounts for just one aspect of the cost of alcohol to society, but there are others such as primary care, crime, ambulatory services, and specialist treatment services as well as broader costs such as unemployment and loss of productivity.

The Government has said that everyone has a role to play in reducing the harmful use of alcohol. This indicator is one of the key contributions by the Government (and the Department of Health and Social Care) to promote measurable, evidence-based prevention activities at a local level, and supports the national ambitions to reduce harm set out in the Government's Alcohol Strategy. This ambition is part of the monitoring arrangements for the Responsibility Deal Alcohol Network. Alcohol-related admissions can be reduced through local interventions to reduce alcohol misuse and harm.

References: (1) PHE (2020) The Burden of Disease in England compared with 22 peer countries https://www.gov.uk/government/publications/global-burden-of-disease-for-england-international-comparisons/the-burden-of-disease-in-england-compared-with-22-peer-countries-executive-summary

Definition of numerator The total cost (£s) of alcohol-related admissions (Broad). Admissions to hospital where the primary diagnosis is an alcohol-related condition, or a secondary diagnosis is an alcohol-related external cause.

More specifically, hospital admissions records are identified where the admission is a finished episode [epistat = 3]; the admission is an ordinary admission, day case or maternity [classpat = 1, 2 or 5]; it is an admission episode [epiorder = 1]; the sex of the patient is valid [sex = 1 or 2]; there is a valid age at start of episode [startage between 0 and 150 or between 7001 and 7007]; the region of residence is one of the English regions, no fixed abode or unknown [resgor <= K or U or Y]; the episode end date [epiend] falls within the financial year, and an alcohol-attributable ICD10 code appears in the primary diagnosis field [diag_01] or an alcohol-related external cause code appears in any diagnosis field [diag_nn].

For each episode identified, an alcohol-attributable fraction is applied to the primary diagnosis field or an alcohol-attributable external cause code appears in one of the secondary codes based on the diagnostic codes, age group, and sex of the patient. Where there is more than one alcohol-related ICD10 code among the 20 possible diagnostic codes, the code with the largest alcohol-attributable fraction is selected; in the event of there being two or more codes with the same alcohol-attributable fraction within the same episode, the one from the lowest diagnostic position is selected. For a detailed list of all alcohol-attributable diseases, including ICD 10 codes and relative risks, see ‘Alcohol-attributable fractions for England: an update’ (2). Alcohol-related hospital admission episodes were extracted from HES according to the Broad definition and admissions flagged as either elective or non-elective based on the admission method field.

The cost of each admission episode was calculated using the National Cost Collection (published by NHS England) main schedule dataset for the corresponding financial year applied to elective and non-elective admission episodes. The healthcare resource group (HRG) was identified using the HES field SUSHRG [SUS Generated HRG], which is the SUS PbR derived HRG code at episode level. Healthcare Resource Groups (HRGs) are standard groupings of clinically similar treatments which use common levels of healthcare resource. The elective admissions were assigned an average of the elective and day-case costs. The non-electives were assigned an average of the non-elective long stay and non-elective short stay costs. Where the HRG was not available or did not match the National Reference Costs look-up table, an average elective or non-elective cost was imputed. This may result in the cost of these admissions being underestimated. For each record, the AAF was multiplied by the reference cost and the resulting values were aggregated by the required output geographies to provide numerators for the cost per capita indicator.

References: (2) PHE (2020) Alcohol-attributable fractions for England: an update https://www.gov.uk/government/publications/alcohol-attributable-fractions-for-england-an-update

Definition of denominator Mid-year population estimates.

Caveats Not all alcohol-related conditions require inpatient services, so this indicator is only one measure of the alcohol-related health problems in each local area. However, inpatient admissions are easily monitored, and this indicator provides local authorities with a routine method of monitoring the health impacts of alcohol in their local populations.

The Healthcare Resource Group cost assigned to each hospital admission is for the initial admission episode only and doesn’t include costs related to alcohol in any subsequent episodes in the hospital spell. Where the HRG was not available or did not match the National Reference Costs look-up table, an average elective or non-elective cost was imputed. This may result in the cost of these admissions being underestimated. It must be noted that the numerator is based on the financial year and the denominator on calendar mid-year population estimates, e.g., 2019/20 admission rates are constructed from admission counts for the 2019/20 financial year and mid-year population estimates for the 2020 calendar year. Data for England includes records with geography 'No fixed abode'. Alcohol-attributable fractions were not available for children. Conditions where low levels of alcohol consumption are protective (have a negative alcohol-attributable fraction) are not included in the calculation of the indicator. This does not include attendance at Accident and Emergency departments. Hospital Episode Statistics overall is well completed. However, year-on-year variations exist due to poor completion from a proportion of trusts.

Analysis has revealed significant differences across the country in the coding of cancer patients in the Hospital Episode Statistics. In particular, in some areas, regular attenders at hospital for treatments like chemotherapy and radiotherapy are being incorrectly recorded as ordinary or day-case admissions. Since cancer admissions form part of the overarching alcohol-related admission national indicators, the inconsistent recording across the country for cancer patients has some implication for these headline measures.

Cancer admissions make up approximately a quarter of the total number of alcohol-related admissions. Analysis suggests that, although most Local Authorities would remain within the same RAG group compared with the England average if cancer admissions were removed, the ranking of Local Authorities within RAG groups would be altered. We are continuing to monitor the impact of this issue and to consider ways of improving the consistency between areas. The COVID-19 pandemic had a large impact on hospital activity with a reduction in admissions in 2020 to 2021. Because of this, NHS Digital has been unable to analyse coverage (measured as the difference between expected and actual records submitted by NHS Trusts) in the normal way. There may have been issues around coverage in some areas which were not identified as a result.

This horizontal bar chart displays hospital beds (per 1,000 people) by countries yearly using the aggregation average, weighted by population in the United Kingdom. The data is filtered where the date is 2021. The data is about countries per year.

Between July and September 2019, there were almost 1.5 million admissions to NHS hospitals in England. Over the provided time interval, that is the quarter with the highest number of admissions.

Busiest hospitals in England

During the financial year 2018/19, the busiest hospital provider in England was the University Hospitals Birmingham Foundation Trust with almost 393.6 thousand admissions. This trust encompasses four hospitals in the Birmingham area, one of the largest urban areas in England. The second busiest trust in this year was the Manchester University Foundation Trust with approximately 315.7 thousand admissions.

Emergency admissions

In the period 2018/19, there were over six million accident and emergency (A&E) attendees in each quarter of the year in England. Prior to 2017/18, no previous quarter in England since 2012 had reached six million A&E attendances, indicating an increasing number of individuals are seeking emergency care. Approximately 5.1 percent of A&E attendees in England in 2018/19 were primarily diagnosed with a dislocation, fracture, joint injury, or an amputation, followed by 5 percent diagnosed with a respiratory condition. Although 4.7 percent were found to have ‘nothing abnormal detected’ which could be detrimental to a service that is already stretched.

OMOP dataset: Hospital COVID patients: severity, acuity, therapies, outcomes Dataset number 2.0

Coronavirus disease 2019 (COVID-19) was identified in January 2020. Currently, there have been more than 6 million cases & more than 1.5 million deaths worldwide. Some individuals experience severe manifestations of infection, including viral pneumonia, adult respiratory distress syndrome (ARDS) & death. There is a pressing need for tools to stratify patients, to identify those at greatest risk. Acuity scores are composite scores which help identify patients who are more unwell to support & prioritise clinical care. There are no validated acuity scores for COVID-19 & it is unclear whether standard tools are accurate enough to provide this support. This secondary care COVID OMOP dataset contains granular demographic, morbidity, serial acuity and outcome data to inform risk prediction tools in COVID-19.

PIONEER geography The West Midlands (WM) has a population of 5.9 million & includes a diverse ethnic & socio-economic mix. There is a higher than average percentage of minority ethnic groups. WM has a large number of elderly residents but is the youngest population in the UK. Each day >100,000 people are treated in hospital, see their GP or are cared for by the NHS. The West Midlands was one of the hardest hit regions for COVID admissions in both wave 1 & 2.

EHR. University Hospitals Birmingham NHS Foundation Trust (UHB) is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, 2750 beds & 100 ITU beds. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health”. UHB has cared for >5000 COVID admissions to date. This is a subset of data in OMOP format.

Scope: All COVID swab confirmed hospitalised patients to UHB from January – August 2020. The dataset includes highly granular patient demographics & co-morbidities taken from ICD-10 & SNOMED-CT codes. Serial, structured data pertaining to care process (timings, staff grades, specialty review, wards), presenting complaint, acuity, all physiology readings (pulse, blood pressure, respiratory rate, oxygen saturations), all blood results, microbiology, all prescribed & administered treatments (fluids, antibiotics, inotropes, vasopressors, organ support), all outcomes.

Available supplementary data: Health data preceding & following admission event. Matched “non-COVID” controls; ambulance, 111, 999 data, synthetic data. Further OMOP data available as an additional service.

Available supplementary support: Analytics, Model build, validation & refinement; A.I.; Data partner support for ETL (extract, transform & load) process, Clinical expertise, Patient & end-user access, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services.

This is a publication on maternity activity in English NHS hospitals. This report examines data relating to delivery and birth episodes in 2022-23, and the booking appointments for these deliveries. This annual publication covers the financial year ending March 2023. Data is included from both the Hospital Episodes Statistics (HES) data warehouse and the Maternity Services Data Set (MSDS). HES contains records of all admissions, appointments and attendances for patients admitted to NHS hospitals in England. The HES data used in this publication are called 'delivery episodes'. The MSDS collects records of each stage of the maternity service care pathway in NHS-funded maternity services, and includes information not recorded in HES. The MSDS is a maturing, national-level dataset. In April 2019 the MSDS transitioned to a new version of the dataset. This version, MSDS v2.0, is an update that introduced a new structure and content - including clinical terminology, in order to meet current clinical practice and incorporate new requirements. It is designed to meet requirements that resulted from the National Maternity Review, which led to the publication of the Better Births report in February 2016. This is the fourth publication of data from MSDS v2.0 and data from 2019-20 onwards is not directly comparable to data from previous years. This publication shows the number of HES delivery episodes during the period, with a number of breakdowns including by method of onset of labour, delivery method and place of delivery. It also shows the number of MSDS deliveries recorded during the period, with breakdowns including the baby's first feed type, birthweight, place of birth, and breastfeeding activity; and the mothers' ethnicity and age at booking. There is also data available in a separate file on breastfeeding at 6 to 8 weeks. The count of Total Babies includes both live and still births, and previous changes to how Total Babies and Total Deliveries were calculated means that comparisons between 2019-20 MSDS data and later years should be made with care. Information on how all measures are constructed can be found in the HES Metadata and MSDS Metadata files provided below. In this publication we have also included an interactive Power BI dashboard to enable users to explore key NHS Maternity Statistics measures. The purpose of this publication is to inform and support strategic and policy-led processes for the benefit of patient care. This report will also be of interest to researchers, journalists and members of the public interested in NHS hospital activity in England. Any feedback on this publication or dashboard can be provided to enquiries@nhsdigital.nhs.uk, under the subject “NHS Maternity Statistics”.

Background The Society for Acute Medicine (SAM) Benchmark Audit (SAMBA) is a national benchmark audit of acute medical care. The aim of SAMBA19 is to describe the severity of illness of acute medical patients presenting to Acute Medicine within UK hospitals, speed of assessment, pathway and progress seven days after admission and to provide a comparison for each participating unit with the national average (or ‘benchmark’). On average >150 hospitals take part in this audit per year. SAMBA19 summer audit measured adherence to some of the standards for acute medical care. Acute Medical Units work 24-hours per day and 365 days a year. They are the single largest point of entry for acute hospital admissions and most patients are at their sickest within the first 24-hours of admission. This dataset includes • Total number of patients assessed by acute medicine across ED, AMU and Ambulatory Care. • Medical and nursing levels • Severity of illness • Timeliness in processes of care • Clinical outcomes 7 days after admission PIONEER geography The West Midlands (WM) has a population of 5.9million & includes a diverse ethnic, socio-economic mix. There is a higher than average % of minority ethnic groups. WM has a large number of elderly residents but is the youngest population in the UK. There are particularly high rates of physical inactivity, obesity, smoking & diabetes. WM has a high prevalence of COPD, reflecting the high rates of smoking and industrial exposure. Each day >100,000 people are treated in hospital, see their GP or are cared for by the NHS. This is the SAMBA dataset from 4 NHS hospitals. EHR University Hospitals Birmingham NHS Foundation Trust (UHB) is one of the largest NHS Trusts in England, providing direct acute services & specialist care across four hospital sites, with 2.2 million patient episodes per year, 2750 beds & 100 ITU beds. UHB runs a fully electronic healthcare record (EHR) (PICS; Birmingham Systems), a shared primary & secondary care record (Your Care Connected) & a patient portal “My Health”. Scope: These data come from Queen Elizabeth Hospitals Birmingham, Good Hope Hospital, Solihull Hospital and Heartlands Hospital. All admissions in a pre-defined 24-hour period, the severity of illness, patient demographics, co-morbidity, acuity scores, serial, structured data pertaining to care process (timings, staff grades, specialty review, wards) all prescribed & administered treatments (fluids, antibiotics, inotropes, vasopressors, organ support), all outcomes.
Available supplementary data: More extensive data including granular serial physiology, bloods, conditions, interventions, treatments. Ambulance, 111, 999 data, synthetic data. Available supplementary support: Analytics, Model build, validation & refinement; A.I.; Data partner support for ETL (extract, transform & load) process, Clinical expertise, Patient & end-user access, Purchaser access, Regulatory requirements, Data-driven trials, “fast screen” services

In 2022, Germany had by far the largest number of psychiatric hospital beds, amounting to nearly *** thousand. In comparison, there were **** thousand beds in the UK. This statistic displays the number of psychiatric care beds in hospitals in selected European countries in 2022.

The United Kingdom diagnostic imaging equipment market, valued at approximately £1.26 billion in 2025, is projected to experience robust growth, exhibiting a Compound Annual Growth Rate (CAGR) of 5.68% from 2025 to 2033. This expansion is fueled by several key factors. Firstly, the aging population in the UK is leading to an increased prevalence of chronic diseases requiring advanced diagnostic imaging techniques. Secondly, technological advancements in medical imaging, such as the development of AI-powered image analysis and improved resolution in modalities like MRI and CT scans, are driving demand for more sophisticated equipment. Furthermore, increased government funding for healthcare infrastructure and initiatives promoting early disease detection are positively impacting market growth. The market is segmented by modality (MRI, CT, Ultrasound, X-Ray, Nuclear Imaging, Fluoroscopy, Mammography), application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology), and end-user (Hospitals, Diagnostic Centers). The competitive landscape is characterized by a mix of established multinational corporations like GE Healthcare, Siemens Healthineers, and Philips, alongside specialized players focusing on niche technologies. While the market faces potential restraints such as high equipment costs and regulatory hurdles, the overall positive trajectory suggests significant growth opportunities in the coming years, particularly for providers offering cutting-edge technologies and integrated solutions. The market's segmentation offers strategic insights. The MRI segment is likely to dominate due to its superior imaging capabilities for various applications, followed closely by CT scanning. The demand for advanced imaging is strong across all applications, with oncology and cardiology segments experiencing substantial growth due to increased cancer diagnoses and cardiovascular disease prevalence. Hospital end-users are expected to remain the largest segment, however, the growth of private diagnostic centers is also contributing significantly to market expansion. Within the competitive landscape, strategic alliances, acquisitions, and technological innovation are key competitive strategies employed by leading players to maintain their market share and expand their offerings. The UK market's strong emphasis on patient care and early disease detection is expected to remain a vital driver for further market development. Recent developments include: May 2022: GE Healthcare and Alliance Medical signed an agreement to collaborate on a digital solution using data analytics and Al to improve productivity in hospital radiology departments in the United Kingdom., May 2022: InHealth Services received Quality Standard for Imaging (QSI) accreditation in the United Kingdom.. Key drivers for this market are: Rise in the Prevalence of Chronic Diseases, Growing Adoption of Advanced Technologies in Medical Imaging. Potential restraints include: Rise in the Prevalence of Chronic Diseases, Growing Adoption of Advanced Technologies in Medical Imaging. Notable trends are: MRI Segment is Expected to Hold a Significant Market Share Over the Forecast Period.

The European Clinical Data Analytics market in healthcare is experiencing robust growth, projected to reach €6.13 billion in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 29.87% from 2025 to 2033. This expansion is fueled by several key factors. Increasing adoption of electronic health records (EHRs) across European healthcare systems provides a vast reservoir of structured data ripe for analysis. Simultaneously, a rising demand for improved patient outcomes, coupled with the need for more efficient resource allocation, is driving investment in advanced analytics solutions. Furthermore, stringent regulatory requirements, particularly around data privacy (GDPR), are fostering the development of secure and compliant clinical data analytics platforms. The market is segmented by deployment (on-premise, cloud), application (clinical, financial, operational/administrative), and end-user (payers, providers). The cloud deployment model is expected to dominate due to its scalability, cost-effectiveness, and accessibility. Clinical data analytics applications focused on predictive modeling for disease management and personalized medicine are experiencing particularly strong growth, driving the overall market expansion. Key players like IBM, Oracle, Cerner, and McKesson are actively investing in research and development, expanding their product portfolios, and forging strategic partnerships to solidify their market positions. The United Kingdom, Germany, and France represent significant market segments within Europe, reflecting their advanced healthcare infrastructure and technological adoption rates. The sustained growth trajectory is underpinned by several factors. The increasing prevalence of chronic diseases necessitates more effective disease management strategies, which analytics can facilitate. Additionally, the integration of wearable devices and telehealth platforms generates a continuous stream of patient data, further fueling the demand for advanced analytical tools. Competition among providers and payers is intensifying, creating a pressure to optimize operational efficiency and reduce costs, thereby increasing reliance on data-driven insights. However, challenges remain, including data interoperability issues, concerns about data security and privacy, and the need for skilled data scientists and analysts. Addressing these challenges through collaborative efforts between stakeholders, technological advancements, and robust regulatory frameworks will be crucial to unlock the full potential of the European Clinical Data Analytics market in healthcare. Recent developments include: July 2023, Pure Storage, the IT pioneer that delivers the most advanced data storage technology and services, announced that the University Hospital Center of Saint-Etienne, one of the leading university hospitals in Southeast France, is leveraging its portfolio - including Pure1, FlashArray, and its Evergreen architecture to accelerate and secure access to critical data to improve overall patient care and business continuity., June 2023: Flatiron Health, a leading health tech company, collaborated with the Leeds Teaching Hospitals NHS Trust (LTHT), one of Europe's largest acute hospital trusts. In the United Kingdom, the agreement signals a new phase for Flatiron Health to advance research and improve care, treatment and quality of life for patients around the world.. Key drivers for this market are: Reduced Cost of Care and Prediction of Possible Emergency Services, Increasing Evidence-based Activities and Shift from Volume to Value-based Commissioning. Potential restraints include: Reduced Cost of Care and Prediction of Possible Emergency Services, Increasing Evidence-based Activities and Shift from Volume to Value-based Commissioning. Notable trends are: Cloud to Witness Significant Growth.